Real-world Data of Siltuximab for Chinese Patients with Imcd: Combination with BCD Regimen As a Potential Approach for Severe Cases
Annals of Hematology（2025）
Key words
Siltuximab,Idiopathic multicentric castleman disease,Response rate,Combination therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined